Day Before Bharat Biotech's Meet with WHO, Covaxin's Phase 3 Trial Data to be Reviewed by Expert Panel
The phase 3 trial data will clearly state the efficacy of the Covid-19 vaccine. Bharat Biotech, the developers of Covaxin, had already been in the dock for delay in announcing its trial data.
from Top India News- News18.com https://ift.tt/35EiVZA
via IFTTT
from Top India News- News18.com https://ift.tt/35EiVZA
via IFTTT
No comments